龍津藥業—投資者提問：“請問：貴公司是否會在大麻二酚（CBD, C21H30O2）的藥理毒理、藥代動力學、口服生物利用度等領域與上海藥明康德新藥開發有限公司等公司開展合作？”

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---